Immunogenicity of a bivalent Omicron BA.1 COVID-19 booster vaccination in people with HIV in the Netherlands

被引：0
|
作者：
Jongkees, M. J. [1 ,2 ]
Tan, N. H. [3 ]
Geers, D. [4 ]
de Vries, R. D. [4 ]
GeurtsvanKessel, C. H. [4 ]
Hensley, K. S. [1 ,2 ]
Sablerolles, S. G. [3 ]
Bogers, S. [4 ]
Blakaj, B. [5 ]
Afonso, P. Miranda [6 ]
Hansen, B. E. [6 ,7 ,8 ,9 ]
Rijnders, B. J. A. [1 ,2 ]
Brinkman, K. [10 ]
van der Kuy, H. M. [3 ]
Roukens, A. H. E. [11 ]
Rokx, C. [1 ,2 ]
机构：
[1] Erasmus MC, Sect Infect Dis, Dept Internal Med, Rotterdam, Netherlands
[2] Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
[3] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands
[4] Erasmus MC, Dept Virosci, Rotterdam, Netherlands
[5] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands
[6] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
[7] Univ Toronto, IHPME, Toronto, ON, Canada
[8] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[9] Univ Hlth Network, TGHRI, Toronto, ON, Canada
[10] OLVG Hosp, Dept Internal Med & Infect Dis, Amsterdam, Netherlands
[11] Leiden Univ, Dept Infect Dis, Med Ctr, Rotterdam, Netherlands
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
EACS2023:
引用
收藏
页码：305 / 306
页数：2
相关论文
共 50 条
  • [1] Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands
    Jongkees, Marlou J.
    Tan, Ngoc H.
    Geers, Daryl
    de Vries, Rory D.
    Geurtsvankessel, Corine H.
    Hensley, Kathryn S.
    Sablerolles, Roos S. G.
    Bogers, Susanne
    Gommers, Lennert
    Blakaj, Blerdi
    Afonso, Pedro Miranda
    Hansen, Bettina E.
    Rijnders, Bart J. A.
    Brinkman, Kees
    van der Kuy, P. Hugo M.
    Roukens, Anna H. E.
    Rokx, Casper
    AIDS, 2024, 38 (09) : 1355 - 1365
  • [2] Omicron BA.1, BA.2 and COVID-19 Booster Vaccination
    Assawakosri, Suvichada
    Kanokudom, Sitthichai
    Suntronwong, Nungruthai
    Puenpa, Jiratchaya
    Duangchinda, Thaneeya
    Chantima, Warangkana
    Pakchotanon, Pattarakul
    Mongkolsapaya, Juthathip
    Wanlapakorn, Nasamon
    Honsawek, Sittisak
    Poovorawan, Yong
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (08): : 1480 - 1481
  • [3] Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
    Springer, David N.
    Bauer, Michael
    Medits, Iris
    Camp, Jeremy V.
    Aberle, Stephan W.
    Burtscher, Clemens
    Hoeltl, Eva
    Weseslindtner, Lukas
    Stiasny, Karin
    Aberle, Judith H.
    NPJ VACCINES, 2023, 8 (01)
  • [4] Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
    David N. Springer
    Michael Bauer
    Iris Medits
    Jeremy V. Camp
    Stephan W. Aberle
    Clemens Burtscher
    Eva Höltl
    Lukas Weseslindtner
    Karin Stiasny
    Judith H. Aberle
    npj Vaccines, 8
  • [5] Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
    Vasin, Andrey V.
    Stukova, Marina A.
    LANCET INFECTIOUS DISEASES, 2023, 23 (08): : 880 - 881
  • [6] Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
    Habermann, Elisa
    Gieselmann, Lutz
    Tober-Lau, Pinkus
    Klotsche, Jens
    Albach, Fredrik Nils
    Ten Hagen, Alexander
    Zernicke, Jan
    Ahmadov, Elvin
    de Silva, Amanthi Nadira Arumahandi
    Frommert, Leonie Maria
    Kurth, Florian
    Sander, Leif Erik
    Burmester, Gerd R.
    Klein, Florian
    Biesen, Robert
    RMD OPEN, 2022, 8 (02):
  • [7] Distinct cellular and serological cross-reactive responses upon COVID-19 Original/BA.1 bivalent booster vaccination
    Hernandez, Sara Suarez
    de Rond, Lia
    Bogaard-van Maurik, Marjan
    Molenaar, Petra
    van Wijlen, Emma
    Oomen, Debbie
    Bijvank, Elske
    Beckers, Lisa
    Smits, Gaby
    Nicolai, Mioara Alina
    Boer, Mardi
    Rots, Nynke
    Wijmenga, Alienke
    Kaaijk, Patricia
    van Beek, Josine
    van Els, Cecile
    Buisman, Anne-Marie
    de Wit, Jelle
    Brummelman, Jolanda
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1661 - 1661
  • [8] Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
    Zaeck, Luca M.
    Tan, Ngoc H.
    Rietdijk, Wim J. R.
    Geers, Daryl
    Sablerolles, Roos S. G.
    Bogers, Susanne
    van Dijk, Laura L. A.
    Gommers, Lennert
    van Leeuwen, Leanne P. M.
    Rugebregt, Sharona
    Goorhuis, Abraham
    Postma, Douwe F.
    Visser, Leo G.
    Dalm, Virgil A. S. H.
    Lafeber, Melvin
    Kootstra, Neeltje A.
    Huckriede, Anke L. W.
    Haagmans, Bart L.
    van Baarle, Debbie
    Koopmans, Marion P. G.
    van der Kuy, P. Hugo M.
    Geurtsvankessel, Corine H.
    de Vries, Rory D.
    NATURE COMMUNICATIONS, 2024, 15 (01) : 4224
  • [9] BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England
    Andrews, Nick
    Stowe, Julia
    Miller, Elizabeth
    Ramsay, Mary
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (02): : 184 - 185
  • [10] Immune response to Wuhan-Omicron bivalent booster COVID-19 vaccination in patients with CLL
    Roberts, Thomas
    Bentley, Christopher
    Uwenedi, Grace
    McIlroy, Graham
    Bruton, Rachel
    Zuo, Jianmin
    Willett, Brian
    Logan, Nicola
    Scott, Sam
    Pratt, Guy
    Paneesha, Shankara
    Moss, Paul
    Parry, Helen
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 15 - 16
12345